Genentech Inc., South San Francisco, CA, USA.
IGM Biosciences, Mountain View, CA, USA.
Immunity. 2020 Jan 14;52(1):17-35. doi: 10.1016/j.immuni.2019.12.011.
Cancer immunotherapy is a validated and critically important approach for treating patients with cancer. Given the vast research and clinical investigation efforts dedicated to advancing both endogenous and synthetic immunotherapy approaches, there is a need to focus on crucial questions and define roadblocks to the basic understanding and clinical progress. Here, we define ten key challenges facing cancer immunotherapy, which range from lack of confidence in translating pre-clinical findings to identifying optimal combinations of immune-based therapies for any given patient. Addressing these challenges will require the combined efforts of basic researchers and clinicians, and the focusing of resources to accelerate understanding of the complex interactions between cancer and the immune system and the development of improved treatment options for patients with cancer.
癌症免疫疗法是一种经过验证的、至关重要的治疗癌症患者的方法。鉴于为推进内源性和合成免疫疗法所付出的大量研究和临床调查努力,我们需要关注关键问题,并确定基本理解和临床进展的障碍。在这里,我们定义了癌症免疫疗法面临的十个关键挑战,这些挑战从缺乏对临床前发现的信心到为任何特定患者确定最佳的免疫治疗组合不等。应对这些挑战需要基础研究人员和临床医生的共同努力,以及资源的集中,以加速理解癌症与免疫系统之间的复杂相互作用,并为癌症患者开发出更好的治疗选择。